ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,000 | -46.7% | 2,815 | -26.6% | 0.00% | – |
| Q4 2019 | $15,000 | -25.0% | 3,835 | 0.0% | 0.00% | – |
| Q3 2019 | $20,000 | -16.7% | 3,835 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -20.0% | 3,835 | -9.6% | 0.00% | – |
| Q1 2019 | $30,000 | -3.2% | 4,243 | +15.3% | 0.00% | – |
| Q4 2018 | $31,000 | -57.5% | 3,679 | 0.0% | 0.00% | – |
| Q3 2018 | $73,000 | -23.2% | 3,679 | 0.0% | 0.00% | – |
| Q2 2018 | $95,000 | +28.4% | 3,679 | +19.2% | 0.00% | – |
| Q1 2018 | $74,000 | -43.9% | 3,087 | -19.7% | 0.00% | – |
| Q4 2017 | $132,000 | +41.9% | 3,845 | -13.7% | 0.00% | – |
| Q3 2017 | $93,000 | +50.0% | 4,457 | +25.7% | 0.00% | – |
| Q2 2017 | $62,000 | -15.1% | 3,546 | -15.7% | 0.00% | – |
| Q1 2017 | $73,000 | 0.0% | 4,208 | -1.0% | 0.00% | – |
| Q4 2016 | $73,000 | +170.4% | 4,250 | +150.7% | 0.00% | – |
| Q3 2016 | $27,000 | +3.8% | 1,695 | 0.0% | 0.00% | – |
| Q2 2016 | $26,000 | +8.3% | 1,695 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | – | 1,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |